U.S. Markets closed
  • S&P 500

    3,635.41
    +57.82 (+1.62%)
     
  • Dow 30

    30,046.24
    +454.97 (+1.54%)
     
  • Nasdaq

    12,036.79
    +156.15 (+1.31%)
     
  • Russell 2000

    1,853.53
    +35.23 (+1.94%)
     
  • Crude Oil

    44.78
    -0.13 (-0.29%)
     
  • Gold

    1,804.80
    +0.20 (+0.01%)
     
  • Silver

    23.30
    0.00 (0.00%)
     
  • EUR/USD

    1.1905
    +0.0008 (+0.0714%)
     
  • 10-Yr Bond

    0.8820
    +0.0250 (+2.92%)
     
  • Vix

    21.64
    -1.02 (-4.50%)
     
  • GBP/USD

    1.3360
    +0.0001 (+0.0093%)
     
  • USD/JPY

    104.5140
    +0.0340 (+0.0325%)
     
  • BTC-USD

    19,101.53
    -18.78 (-0.10%)
     
  • CMC Crypto 200

    379.74
    +9.99 (+2.70%)
     
  • FTSE 100

    6,432.17
    +98.33 (+1.55%)
     
  • Nikkei 225

    26,542.81
    +377.22 (+1.44%)
     

Nuance Communications: Q4 Earnings Insights

Benzinga Insights
·1 min read

Shares of Nuance Communications (NASDAQ:NUAN) fell 3.06% after the company reported Q4 results.

Quarterly Results

Earnings per share decreased 45.45% year over year to $0.18, which beat the estimate of $0.16.

Revenue of $352,931,000 declined by 25.01% year over year, which beat the estimate of $345,720,000.

Outlook

Earnings guidance hasn't been issued by the company for now.

Nuance Communications hasn't issued any revenue guidance for the time being.

Details Of The Call

Date: Nov 18, 2020

View more earnings on NUAN

Time: 05:00 PM

ET Webcast URL: https://www.webcaster4.com/Webcast/Page/2424/38228

Technicals

Company's 52-week high was at $36.35

Company's 52-week low was at $13.51

Price action over last quarter: Up 14.86%

Company Profile

Nuance Communications Inc is the pioneer in conversational AI innovations that bring intelligence to everyday work and life. The company delivers solutions that understand, analyze, and respond to people amplifying human intelligence to increase productivity and security. Its operating segment includes Healthcare; Enterprise; Automotive and Other. The company generates maximum revenue from the Healthcare segment. Its Healthcare segment is primarily engaged in providing clinical speech and clinical language understanding solutions that improve the clinical documentation process, from capturing the complete patient record to improving clinical documentation and quality measures for reimbursement. Geographically, it derives a majority of revenue from the United States.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.